UK markets close in 42 minutes

Titan Pharmaceuticals, Inc. (TTNP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
6.94+0.39 (+5.95%)
As of 04:00PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-10,180
-5,569
-10,206
-8,776
-18,242
-
Depreciation & amortisation
204
112
196
221
292
-
Stock-based compensation
1,270
1,013
997
1,505
7
-
Change in working capital
1,018
-916
378
-219
1,018
-
Accounts receivable
-
-
-
-
186
744
Inventory
-331
0
187
35
287
-
Accounts payable
255
-476
-751
-1,191
1,101
-
Other working capital
-7,690
-7,094
-8,183
-7,922
-17,743
-
Other non-cash items
3
23
452
31
482
-
Net cash provided by operating activities
-7,685
-7,092
-8,183
-7,899
-17,203
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-2
-
-23
-540
-256
Other investing activities
-
734
-
-
-
-
Net cash used for investing activities
-5
732
0
-23
-540
-
Cash flows from financing activities
Debt repayment
-
-250
0
0
-1,600
-
Common stock issued
4,980
0
4,980
8,841
11,636
-
Net cash used provided by (used for) financing activities
4,984
10,000
4,984
8,841
17,933
-
Net change in cash
-2,706
3,640
-3,199
919
190
-
Cash at beginning of period
7,418
3,133
6,332
5,413
5,223
-
Cash at end of period
4,712
6,773
3,133
6,332
5,413
-
Free cash flow
Operating cash flow
-7,685
-7,092
-8,183
-7,899
-17,203
-
Capital expenditure
-
-2
-
-23
-540
-256
Free cash flow
-7,690
-7,094
-8,183
-7,922
-17,743
-